Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomised, Multicenter Phase II/III Clinical Trial to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT Versus Placebo

NCT00332280 is registered in ClinicalTrials.gov with Auron Healthcare GmbH as lead sponsor.

NCT NCT00332280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00332280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomised, Multicenter Phase II/III Clinical Trial to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT Versus Placebo
Lead sponsor
Auron Healthcare GmbH
Phase
Phase 2/3
Overall status
Terminated
Start date
May 31, 2006
Completion date
March 31, 2010
Enrollment
67 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer, genital neoplasms, female, prostate cancer